GlassScriptPhysician profile
Ashley Black
NPI 1679823306
$5,004.63
in general payments reported to CMS, 2019-2025
31 companies · $1,068 in 2025
The $1,068 reported for 2025 was more than what 88% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $902 · 2022: $1,193 · 2023: $868 · 2024: $974 · 2025: $1,068.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,910.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,909.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $1,083.74 | 2021-2025 | Lifevest |
| Novartis Pharmaceuticals Corporation | $783.70 | 2021-2025 | |
| Amgen INC. | $539.78 | 2021-2025 | Repatha, Repatha |
| Merck Sharp & Dohme LLC | $506.53 | 2021-2024 | Verquvo |
| Janssen Pharmaceuticals, INC | $321.27 | 2021-2024 | Xarelto |
| Novo Nordisk INC | $286.47 | 2022-2025 | Ozempic, Rybelsus, Wegovy |
| Endotronix, INC. | $280.79 | 2025 | Cordella Pulomonary Artery Pressure Sensor |
| Boehringer Ingelheim Pharmaceuticals, INC. | $270.58 | 2021-2024 | Jardiance |
| Abbott Laboratories | $106.80 | 2021-2025 | Cardiomems, Gallant, Jot Dx |
| Boston Scientific Corporation | $101.96 | 2021-2024 | Bodyguardian |
| Astrazeneca Pharmaceuticals LP | $96.83 | 2021-2024 | Farxiga, Brilinta |
| Edwards Lifesciences Corporation | $69.82 | 2025 | Sapien 3 Ultra Resilia |
| Pfizer INC. | $61.88 | 2021-2024 | |
| E.R. Squibb & Sons, L.L.C. | $60.50 | 2021-2025 | Camzyos |
| Bayer Healthcare Pharmaceuticals INC. | $50.16 | 2025 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kestra Medical Technology Services, INC. | $48.41 | 2025 | Assure Wcd |
| Atricure, INC. | $46.05 | 2024-2025 | Atriclip Laa Exclusion System |
| Abiomed | $33.17 | 2025 | |
| Abbvie INC. | $30.63 | 2025 | |
| Kowa Pharmaceuticals America, INC. | $25.53 | 2021 | |
| Sage Therapeutics, LLC | $23.39 | 2024 | |
| Medicure Pharma INC. | $22.73 | 2022 | |
| Impulse Dynamics (USA) INC. | $21.33 | 2023 | Optimizer |
| Vital Connect, INC | $20.28 | 2025 | Vitalpatch Rtm |
| Esperion Therapeutics, INC. | $18.97 | 2022 | |
| Kiniksa Pharmaceuticals International, Plc | $18.21 | 2024 | Arcalyst |
| Convatec INC. | $18.17 | 2021 | |
| Amryt Pharma Holdings LTD | $17.66 | 2021 | |
| Janssen Biotech, INC. | $14.59 | 2023 | Imbruvica, Darzalex |
| Octapharma USA, INC. | $13.48 | 2025 | Balfaxar |
| Cmp Pharma, INC. | $11.22 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashley Black listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.